Plain-English translation of NCT05267886 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
When your heart suddenly stops pumping blood effectively, doctors may use medications called inotropes—such as or —to strengthen the heartbeat and restore blood flow to vital organs. This study is testing whether these medications actually improve survival and recovery in patients with severe heart shock, or whether they may cause unexpected harm.
Even though this medication has been used for decades in intensive care units, doctors still aren't sure whether it truly saves lives or whether it might actually make outcomes worse. Recent research suggests the evidence is unclear and possibly concerning, so this trial will provide a definitive answer about whether this treatment should continue to be a standard part of care.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the heart-strengthening medication at doses adjusted by your doctors based on your condition, or a placebo saline solution given through an intravenous line. Your medical team will care for you as usual in the intensive care unit, monitoring your heart function and overall recovery while you remain in the hospital.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States
Canada